BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Gefitinib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gefitinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

erlotinib
60 shared targets
canertinib
59 shared targets
vandetanib
50 shared targets
pelitinib
44 shared targets
cediranib
37 shared targets
Afatinib
33 shared targets
doramapimod
37 shared targets
neratinib
40 shared targets
foretinib
58 shared targets
nilotinib
30 shared targets
Loading evidence profile...

This evidence profile for Gefitinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.